Study of liver transplant outcomes for liver cancer
Part of Cancer, Digestive system clinical trials.
This study examines medical records from patients who received a liver transplant for hepatocellular carcinoma (a type of liver cancer) between 2018 and 2023. The goal is to understand treatment outcomes and improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You received a liver transplant between January 2018 and December 2023
- Your transplant was specifically for hepatocellular carcinoma (HCC), confirmed by imaging or biopsy
- You have not objected to researchers using your medical data for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well patients with liver cancer do after receiving a living donor liver transplant that is not the same blood type. It compares survival and cancer return for these patients.
This study uses computer algorithms, biological markers, and surveys about well-being to create personalized care plans for people who have received a heart or liver transplant. It aims to find better ways to monitor and manage your health after transplant.
This study looks at how well different combinations of interventional procedures (like TACE) and systemic treatments (like targeted therapy or immunotherapy) work for liver cancer. It uses real-world data to find which combinations might be best for different patients.
This study reviews medical records of people diagnosed with hepatocellular carcinoma (liver cancer) between 2015 and 2023 to better understand how the disease progresses and how different treatments work. Your information helps researchers learn what care approaches work best for future patients.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
This study collects data from adults listed for liver transplants due to severe liver disease or liver cancer. It aims to improve transplant care by learning from real-world patient information.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.